Literature DB >> 26476218

The Epidemiology of Psoriatic Arthritis.

Alexis Ogdie1, Pamela Weiss2.   

Abstract

Psoriatic arthritis (PsA) is a chronic systemic inflammatory disorder characterized by joint and entheseal inflammation with a prevalence of 0.05% to 0.25% of the population and 6% to 41% of patients with psoriasis. PsA is a highly heterogeneous inflammatory arthritis. In this review, current knowledge is discussed regarding the epidemiology of PsA, including disease manifestations, classification criteria for adult and juvenile PsA, methods for recognizing early PsA, including use of screening tools and knowledge of risk factors for PsA, and medical comorbidities associated with PsA.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Classification criteria; Comorbidity; Epidemiology; Juvenile psoriatic arthritis; Psoriatic arthritis; Risk factors; Screening tools

Mesh:

Year:  2015        PMID: 26476218      PMCID: PMC4610151          DOI: 10.1016/j.rdc.2015.07.001

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  190 in total

1.  Nail psoriasis in Germany: epidemiology and burden of disease.

Authors:  M Augustin; K Reich; C Blome; I Schäfer; A Laass; M A Radtke
Journal:  Br J Dermatol       Date:  2010-04-28       Impact factor: 9.302

2.  Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis.

Authors:  Daniel H Solomon; Thorvardur Jon Love; Claire Canning; Sebastian Schneeweiss
Journal:  Ann Rheum Dis       Date:  2010-06-28       Impact factor: 19.103

3.  The electronic Psoriasis and Arthritis Screening Questionnaire (ePASQ): a sensitive and specific tool to diagnose psoriatic arthritis patients.

Authors:  Majed Khraishi; Jonathan Mong; Gerry Mugford; Ian Landells
Journal:  J Cutan Med Surg       Date:  2011 May-Jun       Impact factor: 2.092

4.  The distribution of juvenile idiopathic arthritis in the eastern Mediterranean: results from the registry of the Turkish Paediatric Rheumatology Association.

Authors:  Erkan Demirkaya; Seza Ozen; Yelda Bilginer; Nuray Aktay Ayaz; Balahan Bora Makay; Erbil Unsal; Muferet Erguven; Hakan Poyrazoglu; Ozgur Kasapcopur; Faysal Gok; Sema Akman; Ayse Balat; Ozlem Cavkaytar; Bulent Kaya; Ali Duzova; Fatih Ozaltin; Rezan Topaloglu; Nesrin Besbas; Aysin Bakkaloglu; Nil Arisoy; Huri Ozdogan; Sevcan Bakkaloglu; Turker Turker
Journal:  Clin Exp Rheumatol       Date:  2011-02-23       Impact factor: 4.473

5.  Incidence and prevalence of psoriatic arthritis in Buenos Aires, Argentina: a 6-year health management organization-based study.

Authors:  Enrique R Soriano; Javier Rosa; Edson Velozo; Monica Schpilberg; Patricia M Imamura; Jorge Diaz; Luis J Catoggio
Journal:  Rheumatology (Oxford)       Date:  2010-12-06       Impact factor: 7.580

6.  Incidence of arthritis in a prospective cohort of psoriasis patients.

Authors:  Lihi Eder; Vinod Chandran; Hua Shen; Richard J Cook; Sutha Shanmugarajah; Cheryl F Rosen; Dafna D Gladman
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-04       Impact factor: 4.794

7.  A comparative study of periarticular bone lesions in rheumatoid arthritis and psoriatic arthritis.

Authors:  Stephanie Finzel; Matthias Englbrecht; Klaus Engelke; Christian Stach; Georg Schett
Journal:  Ann Rheum Dis       Date:  2010-10-11       Impact factor: 19.103

8.  The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general.

Authors:  M Rudwaleit; D van der Heijde; R Landewé; N Akkoc; J Brandt; C T Chou; M Dougados; F Huang; J Gu; Y Kirazli; F Van den Bosch; I Olivieri; E Roussou; S Scarpato; I J Sørensen; R Valle-Oñate; U Weber; J Wei; J Sieper
Journal:  Ann Rheum Dis       Date:  2010-11-24       Impact factor: 19.103

Review 9.  The early phase of psoriatic arthritis.

Authors:  Dennis McGonagle; Zoe Ash; Laura Dickie; Michael McDermott; Sibel Zehra Aydin
Journal:  Ann Rheum Dis       Date:  2011-03       Impact factor: 19.103

10.  Whole-body MR imaging in psoriatic arthritis: additional value for therapeutic decision making.

Authors:  Sabine Weckbach; Stefan Schewe; Henrik J Michaely; Denise Steffinger; Maximilian F Reiser; Christian Glaser
Journal:  Eur J Radiol       Date:  2009-07-24       Impact factor: 3.528

View more
  98 in total

Review 1.  Early Recognition and Treatment Heralds Optimal Outcomes: the Benefits of Combined Rheumatology-Dermatology Clinics and Integrative Care of Psoriasis and Psoriatic Arthritis Patients.

Authors:  Teo Soleymani; Soumya M Reddy; Jeffrey M Cohen; Andrea L Neimann
Journal:  Curr Rheumatol Rep       Date:  2017-11-20       Impact factor: 4.592

2.  Long-term etanercept survival in patients with psoriatic arthritis: a multicenter retrospective analysis in daily clinical practice in Spain.

Authors:  Gustavo Deza; Jaime Notario; Marta Ferran; Emma Beltrán; Miriam Almirall; Rebeca Alcalá; José Carlos Ruiz-Carrascosa; Ricardo Sánchez; Silvia Pérez; María Luz García-Vivar; Eva Galíndez; Maribel Mora; Jesús Rodríguez; Fernando Gallardo
Journal:  Rheumatol Int       Date:  2018-08-24       Impact factor: 2.631

3.  Patterns of Systemic Treatment for Psoriatic Arthritis in the US: 2004-2015.

Authors:  Moa P Lee; Joyce Lii; Yinzhu Jin; Rishi J Desai; Daniel H Solomon; Joseph F Merola; Seoyoung C Kim
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-03-23       Impact factor: 4.794

Review 4.  Clinical Risk Factors for the Development of Psoriatic Arthritis Among Patients with Psoriasis: A Review of Available Evidence.

Authors:  Alexis Ogdie; J M Gelfand
Journal:  Curr Rheumatol Rep       Date:  2015-10       Impact factor: 4.592

Review 5.  Psoriatic arthritis and psoriasis: differential diagnosis.

Authors:  Maddalena Napolitano; Francesco Caso; Raffaele Scarpa; Matteo Megna; Angela Patrì; Nicola Balato; Luisa Costa
Journal:  Clin Rheumatol       Date:  2016-05-07       Impact factor: 2.980

Review 6.  IL-23/IL-17 Axis in Inflammatory Rheumatic Diseases.

Authors:  Hao Li; George C Tsokos
Journal:  Clin Rev Allergy Immunol       Date:  2020-11-13       Impact factor: 8.667

7.  [Cross-sectional study on clinic behavior and therapeutic status of patients with psoriatic arthritis in multi-center].

Authors:  Y H Li; B Su; F A Lin; Y N Fei; X X Yu; W Q Fan; H Y Chen; X W Zhang; Y Jia
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-12-18

8.  Mapping Quality of Life (EQ-5D) from DAPsA, Clinical DAPsA and HAQ in Psoriatic Arthritis.

Authors:  Tomas Mlcoch; Jan Tuzil; Liliana Sedova; Jiri Stolfa; Monika Urbanova; David Suchy; Andrea Smrzova; Jitka Jircikova; Tereza Hrnciarova; Karel Pavelka; Tomas Dolezal
Journal:  Patient       Date:  2018-06       Impact factor: 3.883

9.  Serum IFI16 and anti-IFI16 antibodies in psoriatic arthritis.

Authors:  M De Andrea; M De Santis; V Caneparo; E Generali; S Sirotti; N Isailovic; G M Guidelli; A Ceribelli; M Fabbroni; A Simpatico; L Cantarini; P Gisondi; L Idolazzi; M Gariglio; C Selmi
Journal:  Clin Exp Immunol       Date:  2019-10-15       Impact factor: 4.330

10.  Frequency of inflammatory-like MR imaging findings in asymptomatic fingers of healthy volunteers.

Authors:  Christoph A Agten; Andrea B Rosskopf; Maciej Jonczy; Florian Brunner; Christian W A Pfirrmann; Florian M Buck
Journal:  Skeletal Radiol       Date:  2017-11-06       Impact factor: 2.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.